SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-126863
Filing Date
2021-04-22
Accepted
2021-04-22 17:02:10
Documents
10
Period of Report
2021-06-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A d57994ddef14a.htm DEF 14A 331631
2 GRAPHIC g57994dsp2b.jpg GRAPHIC 1024
3 GRAPHIC g57994dsp3a.jpg GRAPHIC 2275
4 GRAPHIC g57994dsp3b.jpg GRAPHIC 1098
5 GRAPHIC g57994dsp3c.jpg GRAPHIC 949
6 GRAPHIC g57994dsp3d.jpg GRAPHIC 1232
7 GRAPHIC g57994dsp3e.jpg GRAPHIC 1391
8 GRAPHIC g57994dsp4a.jpg GRAPHIC 978
9 GRAPHIC g57994g23u32.jpg GRAPHIC 65162
10 GRAPHIC g57994g65d12.jpg GRAPHIC 46326
  Complete submission text file 0001193125-21-126863.txt   499884
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38268 | Film No.: 21845498
SIC: 2836 Biological Products, (No Diagnostic Substances)